SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ipca Laboratories informs about disclosure

20 Sep 2024 Evaluate

Ipca Laboratories has informed that the Company has received an Order in Appeal from the Joint Commissioner (Appeals), CGST Jaipur under Section 107 of the CGST Act, 2017 for the financial year 2017-18, details are disclosed enclosed.

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories Share Price

1543.95 13.35 (0.87%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.75
Dr. Reddys Lab 1270.95
Cipla 1333.55
Zydus Lifesciences 911.85
Lupin 2343.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×